Phase 1 dose-escalation study of CP-690 550 in stable renal allograft recipients: Preliminary findings of safety, tolerability, effects on lymphocyte subsets and pharmacokinetics

E. Van Gurp, W. Weimar, R. Gaston, D. Brennan, R. Mendez, J. Pirsch, S. Swan, M. D. Pescovitz, G. Ni, C. Wang, S. Krishnaswami, V. Chow, G. Chan

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase 1 dose-escalation study of CP-690 550 in stable renal allograft recipients: Preliminary findings of safety, tolerability, effects on lymphocyte subsets and pharmacokinetics'. Together they form a unique fingerprint.

Medicine & Life Sciences